Published in AIDS Weekly, May 26th, 1997
The technique uses viral genes that have been altered so that the antigens they express are presented to the immune system far more efficiently than they are during normal virus replication. Such vaccines theoretically could be adapted to express altered antigens from other intracellular pathogens or tumor cells, and could be used to prevent or treat disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.